Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
1. LFWD received CE mark approval for ReWalk 7 Exoskeleton in Europe. 2. ReWalk 7 features cloud connectivity and customizable walking speeds. 3. 40% of LFWD's exoskeleton sales come from European customers. 4. Reimbursement established in Germany supports revenue growth for LFWD. 5. Success in Europe may lead to expansion in other markets including the U.S.